Linzhu Zhai
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective study.
Journal: Annals of hematology
Published: October 22, 2025
Role of Surgical Therapy in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma and Development of a Survival Nomogram.
Journal: Annals of surgical oncology
Published: September 29, 2025
Bleomycin-induced flagellate-like skin pigmentation in a 15-year-old girl: a case report and review.
Bleomycin-induced flagellate-like skin pigmentation in a 15-year-old girl: a case report and review.
Journal: Frontiers in medicine
Published: April 14, 2025
Safety and efficacy of rechallenge with immune checkpoint inhibitors and anlotinib in advanced non-small cell lung cancer without targetable driver mutations: a retrospective analysis.
Journal: BMC cancer
Published: January 02, 2025
Age-related differences in primary central nervous system lymphomas based on the SEER database.
Journal: Frontiers in medicine
Published: November 26, 2024
A prognostic index for advanced-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
Journal: Annals of hematology
Published: September 04, 2024
Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer.
Journal: Frontiers in oncology
Published: June 26, 2024
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Journal: Leukemia
Published: November 22, 2023
MYC-dependent MiR-7-5p regulated apoptosis and autophagy in diffuse large B cell lymphoma by targeting AMBRA1.
Journal: Molecular and cellular biochemistry
Published: September 22, 2023
Comparison and Analysis of the Drug-Resistance Mechanism of Osimertinib- and Almonertinib-Resistant Cell Lines.
Journal: Analytical cellular pathology (Amsterdam)
Published: August 28, 2023
Onychopathy Following Durvalumab Treatment for Extensive-Stage Small-Cell Lung Cancer: A Case Report.
Journal: Clinical, cosmetic and investigational dermatology
Published: June 21, 2023
First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis.
Journal: The Journal of international medical research
Published: November 16, 2022
Last Updated: 09/26/2026